What is the Turbo® O₂ Cap?

The Turbo® O₂ Cap is a non-sterile airway accessory designed to deliver oxygen where it matters — near the glottis. It attaches to an endotracheal tube (size 5.5 mm- 9.0 mm) and channels 100% oxygen (15 L/min) directly to the area near the vocal cords*. It offers a simple, intuitive, and affordable method to address oxygen desaturation during airway management.

Why Was it Invented?

During emergent intubations, oxygen saturation can fall rapidly, particularly after rapid sequence intubation (RSI) when patients are chemically paralyzed [1]. Current standard practice often includes the use of nasal cannulas for supplemental oxygenation; however, studies have shown that oxygen concentrations measured 10 cm from the nasal prongs rarely exceed 23.5%, even at high flow rates [2]. Given that the distance from the nose to the vocal cords averages 5–7 cm, effective oxygen delivery is suspected to be limited, especially when patients are chemically paralyzed. Turbo® O₂ Cap was developed after the company’s CEO witnessed another near-critical airway case in which a surgical cricothyrotomy was nearly required following repeated failed intubation attempts, highlighting the urgent need for a better solution.

How Does the Turbo® O₂ Cap Work?

In a large porcine model simulating rapid sequence intubation, subjects were sedated and paralyzed, and a laryngoscope was used to elevate the jaw. An endotracheal tube was positioned in the hypopharynx, to the side of the vocal cords without advancing through them, simulating a difficult intubation attempt. In the control group, no oxygen was delivered; oxygen saturation dropped below 75% within one minute. In the test group, using the Turbo® O₂ Cap delivering 100% oxygen at 15 L/min through the ET tube and into the hypopharyngeal space near the glottis, oxygen saturations rose to 99% and remained stable for 15 minutes despite complete paralysis and absence of respiratory movement. This outcome is attributed to passive diffusion, with high-concentration oxygen positioned immediately in front of the vocal cords and lower oxygen concentration present beyond the cords within the lungs, creating a favorable diffusion gradient. While these findings come from an animal model**, human clinical studies are underway, and the Turbo® O₂ Cap is now commercially available in the United States.

Do I Need to Change My Workflow?

Some medical providers insert the laryngoscope into the mouth and then follow by advancing the endotracheal tube alongside it into the oropharynx, preparing to intubate once the vocal cords are visualized. Others prefer to withhold the endotracheal tube outside the mouth until the laryngoscope is positioned, bringing the tube into the airway only once the cords are in view. SharpMed, LLC does not instruct or direct how medical providers should perform intubations. In general, as long as the ET tube is positioned properly within the hypopharynx near the glottic opening a provider may still obtain the potential benefit of enhanced oxygenation***.

Footnotes:

* When the endotracheal tube is positioned properly within the hypopharynx near the glottic opening.
** Results observed in a porcine research model when positioned appropriately.
*** SharpMed, LLC does not instruct medical providers how to practice medicine, including intubation techniques. Providers should use the Turbo® O₂ Cap according to the Instructions for Use (IFU) and established standards of good clinical practice. When properly positioned near the glottic opening, the Turbo® O₂ Cap delivers 100% oxygen to the glottic region — supporting oxygenation during intubation.

References:

[1] Bodily, D.A., et al., “Incidence and Duration of Continuously Measured Oxygen Desaturation During Emergency Department Rapid Sequence Intubation,” Annals of Emergency Medicine, Vol. 67, No. 3, 2016, pp. 389–395. https://doi.org/10.1016/j.annemergmed.2015.06.006

[2] Lumb, A.B., and Slinger, P., “Hypoxaemia in the Postoperative Period: Oxygen Physiology and Monitoring,” Anaesthesia, Vol. 63, No. 5, 2008, pp. 564–569. https://doi.org/10.1111/j.1365-2044.2008.05820.x

Videos

Turbo® O₂ Cap

Turbo® O₂ Cap Testimonial by Dr. Brion Benninger

Turbo® O₂ Cap: Preventing Oxygen Desaturation During Simulated Difficult Intubation

Turbo® O₂ Cap Inservice Demo

If You Could See Oxygen Would You Intubate Differently

Demonstrating the Turbo® O₂ Cap in Adult Manikin Intubation

Demonstrating the Turbo® O₂ Cap in Pediatric Intubation

The 14 CM Problem: Why Nasal Cannulas Don’t Deliver What You Think

Testimonial – John Hughes (Critical Care Paramedic)

Demonstrating the Turbo® O₂ Cap in Pediatric Intubation

The 14 CM Problem: Why Nasal Cannulas Don’t Deliver What You Think

Testimonial – John Hughes (Critical Care Paramedic)

Dr. Chris Salvino: Turbo® O2 Cap – A Novel glottic Oxygenation Device

Eliminating Hypoxia During Paralytic Intubation: A Progressive Animal Series
Presented at the Pulmonary and Respiratory Diesease Conference – Vienna, Austria

First-Pass Success: Why 90% Still Isn’t Enough | Advanced Airway Management & Turbo® O₂ Cap

Journal Publications

Airway, June 2026

A Novel Oxygenation Device, the Turbo® O₂ Cap, Prevents Hypoxia for 15 Minutes of Apnea in a Porcine Model, Despite Paralysis: A Potential Paradigm Shift in Human Airway Management

BMC Anesthesiology, February 2026

Extending the Safe Apnea Window: Preclinical Evaluation of the Turbo® O₂ Cap for Hypoxia Mitigation During Difficult Intubation

The American Journal of Emergency Medicine, February 2026

Impact of Turbo® O₂Cap on safe apnea period in intubation: A proof-of-concept crossover study using a porcine model

Journal of Medical Devices,
April 2023

Development of an Endotracheal Tube Cap for Oxygen Delivery During Intubation

Conference Presentations

Canadian Association of Emergency Physicians Annual Conference, June 2026

A Novel Oxygenation Device, the Turbo® O₂ Cap, Prevents Hypoxia for 15minutes of Apnea in a Porcine Model, despite paralysis: A Potential Paradigm Shift in Human Airway Management

California Society for Respiratory Care Conference (CSRC SoCal 2026), April 2026

Eliminating Hypoxia During Paralytic Intubation: A Progressive Animal Series

AzCEP Annual Scientific Assembly, April 2026

Building Toward Elimination of Hypoxia During Apnea: A Progressive Animal
Model Study of Oxygen Delivery at the Vocal Cords

WACEP Symposium & 34th Annual EM Research Forum, April 2026

Building Toward Elimination of Hypoxia During Apnea: A Progressive Animal
Model Study of Oxygen Delivery at the Vocal Cords

Houston Shock Symposium: Cardiogenic Shock Conference, March 2026

Apneic Oxygenation for Fifteen Minutes Achieved Using a Commercial Device in a Paralyzed Porcine Model

American Association for Anatomy:  Anatomy Connected, March 2025

Efficacy of Nasal Canula Delivering Supplemental Oxygen During Intubation with Novel GAX-specimen Donor Cadavers

Society of Obstetric Anesthesia and Perinatology, May 2024

Assessing the Efficacy of an Innovative Airway Device Delivering Supplemental Oxygen During Intubation with GAX-specimen

Society of Academic Emergency Medicine, May 2023

Safe Apnea Period of > 16 Minutes Using Novel ET Tube Device in Porcine RSK Model 

Marketing Materials

Turbo® O₂ Cap Technology One Pager

Turbo® O₂ Cap One Page Research Summary

Hypoxia Strategic Summary Paper

Information For Use

Current

Archived

Frequently Asked Questions (FAQ)

Where will I find the Instructions for Use (IFU)?

The Instructions for Use (IFU) can be found on our website under marketing materials. We keep current as well as archived IFUs here. Turbo® O₂ Cap IFU 

What is the Turbo® O₂ Cap?

The Turbo® O₂ Cap is a non-sterile airway accessory designed to support oxygenation during difficult or urgent intubations. It attaches to an endotracheal tube (size 5.5 mm–9.0 mm) and channels 100% oxygen (15 L/min) directly to the area near the vocal cords*. It offers a simple, intuitive, and affordable method to address oxygen desaturation during airway management.

* When the endotracheal tube is positioned properly within the hypopharynx near the glottic opening.
Why Was the Turbo® O₂ Cap Invented?

During emergent intubations, oxygen saturation can fall rapidly, particularly after rapid sequence intubation (RSI) when patients are chemically paralyzed [1]. Current standard practice often includes the use of nasal cannulas for supplemental oxygenation; however, studies have shown that oxygen concentrations measured 10 cm from the nasal prongs rarely exceed 23.5%, even at high flow rates [2]. Given that the distance from the nose to the vocal cords averages 5–7 cm, effective oxygen delivery is suspected to be limited, especially when patients are chemically paralyzed. Turbo® O₂ Cap was developed after the company’s CEO witnessed another near-critical airway case in which a surgical cricothyrotomy was nearly required following repeated failed intubation attempts, highlighting the urgent need for a better solution.

[1] Bodily, D.A., et al., “Incidence and Duration of Continuously Measured Oxygen Desaturation During Emergency Department Rapid Sequence Intubation,” Annals of Emergency Medicine, Vol. 67, No. 3, 2016, pp. 389–395.
https://doi.org/10.1016/j.annemergmed.2015.06.006
[2] Lumb, A.B., and Slinger, P., “Hypoxaemia in the Postoperative Period: Oxygen Physiology and Monitoring,” Anaesthesia, Vol. 63, No. 5, 2008, pp. 564–569.
https://doi.org/10.1111/j.1365-2044.2008.05820.x
How Does the Turbo® O₂ Cap Work?

In a large porcine model simulating rapid sequence intubation, subjects were sedated and paralyzed, and a laryngoscope was used to elevate the jaw. An endotracheal tube was positioned in the hypopharynx, to the side of the vocal cords without advancing through them, simulating a difficult intubation attempt. In the control group, no oxygen was delivered; oxygen saturation dropped below 75% within one minute. In the test group, using the Turbo® O₂ Cap delivering 100% oxygen at 15 L/min through the ET tube and into the hypopharyngeal space near the glottis, oxygen saturations rose to 99% and remained stable for 15 minutes despite complete paralysis and absence of respiratory movement. This outcome is attributed to passive diffusion, with high-concentration oxygen positioned immediately in front of the vocal cords and lower oxygen concentration present beyond the cords within the lungs, creating a favorable diffusion gradient. While these findings come from animal model**, human clinical studies are underway, and the Turbo® O₂ Cap is now commercially available in the United States.

** Results observed in a human-analog (porcine) research model when positioned appropriately.
Do I Need to Change My Workflow?

Some medical providers insert the laryngoscope into the mouth and then follow by advancing the endotracheal tube alongside it into the oropharynx, preparing to intubate once the vocal cords are visualized. Others prefer to withhold the endotracheal tube outside the mouth until the laryngoscope is positioned, bringing the tube into the airway only once the cords are in view. SharpMed, LLC does not instruct or direct how medical providers should perform intubations. In general, as long as the ET tube is positioned properly within the hypopharynx near the glottic opening a provider may still obtain the potential benefit of enhanced oxygenation***.

*** SharpMed, LLC does not instruct medical providers how to practice medicine, including intubation techniques. Providers should use the Turbo® O₂ Cap according to the Instructions for Use (IFU) and established standards of good clinical practice. The Turbo® O₂ Cap delivering 100% oxygen can deliver oxygen near the glottic inlet during apnea  and support oxygenation during difficult intubations only if the device is properly positioned in the hypopharynx near the glottic opening.
What about heavy secretions or suctioning?

The Turbo® O₂ Cap can remain in place during suctioning. It continues to deliver oxygen while you clear secretions.

Does the Turbo® O₂ Cap help even if I preoxygenate to 94% before intubation?

The device was designed to help minimize support oxygenation no matter what the starting point is. Even with preoxygenation to 94%, oxygen levels can drop quickly during intubation, and the Turbo® O₂ Cap continues delivering oxygen throughout the attempt.

Can the Turbo® O₂ Cap be used during bronchoscopy?

No, the conforming valve is strictly for the insertion of a stylet and is not intended to introduce other tools or medication.

Does the Turbo® O₂ Cap connect to standard oxygen tubing?

Yes. It should connect to standard oxygen extension tubing with a female adaptor on both ends of the tubing.

How does the Turbo® O₂ Cap compare to high-flow nasal cannulas?

While there has been no direct study comparing nasal cannulas to the Turbo® O₂ Cap, the big difference is the ability of the Turbo O₂ Cap to deliver oxygen much closer to the vocal cords.

What flow rate should I use?

15 L/min.

Can the Turbo® O₂ Cap be used in the United States?

Yes. The Turbo® O₂ Cap is a U.S. Class I medical device.

Can I use the Turbo® O₂ Cap in non-emergent cases?

It is suitable for both urgent and elective intubations, as you never know for sure when a difficult airway may arise.

What’s the difference between the Turbo® O₂ Cap and preoxygenation?

Preoxygenation fills the lungs before apnea. The Turbo® O₂ Cap delivers oxygen during apnea.

Does the Turbo® O₂ Cap have any contraindications or warnings?

Yes. Please refer to the Instructions for Use (IFU) document for full details. Turbo® O₂ Cap IFU

Is the Turbo® O₂ Cap reusable?

No. Single-use only.

What ET tube sizes is the Turbo® O₂ Cap compatible with?

Inner diameter (I.D.) 5.5 mm to 9.0 mm.

What stylet sizes are compatible with the Turbo® O₂ Cap?

Refer to Table 1 in the IFU for specific pairings. Turbo® O₂ Cap IFU

Can the Turbo® O₂ Cap be used with a bougie?

No, the conforming valve is strictly for the insertion of a stylet and is not intended to introduce other tools or medication.

When should I take the Turbo® O₂ Cap off the ET tube?

Ideally as soon as intubation is successful and the ET tube balloon is inflated.

What about gastric inflation or aspiration risk?

We do not believe the Turbo adds significant gastric inflation risk, based on a few key factors:
– With the laryngoscope in place, the airway is open, and excess gas escapes out the mouth
– In our animal lab, stomach x-rays taken before and after 16-minute simulated intubations showed minimal to no gas inflation

That said, aspiration is a real and inherent risk of emergency intubation — and that risk exists regardless of our device. All standard precautions to prevent aspiration should always be used.



Want to Place an Order?

630-232-8002 opt. 1

orders@sharpmed.com